Page last updated: 2024-09-04

moxifloxacin and Airflow Obstruction, Chronic

moxifloxacin has been researched along with Airflow Obstruction, Chronic in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (21.62)	29.6817
2010's	27 (72.97)	24.3611
2020's	2 (5.41)	2.80

Authors

Authors	Studies
Lamb, YN; Lee, A; Shirley, M	1
Chen, Y; Li, Z; Meng, W; Xiong, R; Zeng, H; Zhao, Z	1
Li, HQ; Ning, W; Wang, JX; Zhang, F	1
Acat, M; Benli, AR; Casim, H; Çetinkaya, E; Çörtük, M; Köroğlu, M; Yazıcı, O	1
Borrego, J; Cobo, F; Navarro-Marí, JM; Rodríguez-Granger, J; Sampedro, A	1
Herath, SC; Maisey, S; Normansell, R; Poole, P	1
Chatzika, K; Kioumis, I; Kontou, P; Manika, K; Pitsiou, G; Sionidou, M; Zarogoulidis, P	1
Diethelm, M; Schuster, S	1
Conget, F; de la Roza, C; Domenech, A; García-Polo, C; Miravitlles, M; Villegas, G	1
Herath, SC; Poole, P	1
Anzueto, A; Arvis, P; Haverstock, D; Miravitlles, M; Sethi, S; Trajanovic, M; Wilson, R	1
Allinson, JP; Brill, SE; Calverley, PM; Cookson, WO; Donaldson, GC; El-Emir, E; Hurst, JR; James, P; Law, M; Maddox, V; McHugh, TD; Moffatt, MF; Nazareth, I; Sweeting, MJ; Wedzicha, JA	1
Alder, J; Anzueto, A; Arvis, P; Haverstock, D; Miravitlles, M; Sethi, S; Trajanovic, M; Wilson, R	2
Hong, X; Lai, G; Lin, Q; Lin, T; Liu, K; Liu, S	1
Chikosi, SJ; Jungck, D; Knobloch, J; Koch, A; Rupp, J; Yanik, S	1
Chang, JH; Choi, EG; Kim, HK; Kwon, YS; Kyung, SY; Lee, JH; Oh, YM; Park, MJ; Rhee, CK; Yoo, KH	1
Green, M; Mehta, R; Patel, B; Wagg, J	1
Gent, JF; Holden, PN; Kong, Y; Murphy, TF; Pettigrew, MM; Sethi, S; Tsuji, BT	1
de la Roza, C; Esquinas, C; García, M; Hervás, R; Marín, A; Millares, L; Miravitlles, M; Monsó, E; Morera, J; Torres, A; Vilà, S	1
Anzueto, A; Ewig, S; Legnani, D; Miravitlles, M; Stauch, K	1
Jones, PW; Miravitlles, M; Rubinstein, E; Sethi, S; Theron, MS; Wedzicha, JA; Wilson, R	1
Liu, YN; Wang, D; Wang, Y	1
Jungck, D; Knobloch, J; Koch, A; Müller, K; Schild, K; Urban, K; Yakin, Y	1
Anzueto, A; Arvis, P; Faragó, G; Haverstock, D; Miravitlles, M; Sethi, S; Trajanovic, M; Wilson, R	1
Eraly, SA; Yam, FK	1
Anzueto, A; Ewig, S; Heldner, S; Legnani, D; Miravitlles, M; Stauch, K	1
Boersma, WG	1
Macklin-Doherty, A; Wilson, R	1
Chuchalin, A; Dokic, D; Marschall, HP; Petri, T; Tokić, M; Zakharova, M	1
Miravitlles, M; Torres, A	1
Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K	2
Sethi, S	1
Miravitlles, M	1

Reviews

6 review(s) available for moxifloxacin and Airflow Obstruction, Chronic

Article	Year
Delafloxacin: A Review in Community-Acquired Pneumonia. Drugs, 2022, Volume: 82, Issue:8 Topics: Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive	2022
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). The Cochrane database of systematic reviews, 2018, 10-30, Volume: 10 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). The Cochrane database of systematic reviews, 2013, Nov-28, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic	2013
The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis. Expert review of respiratory medicine, 2012, Volume: 6, Issue:5 Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2012
Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-15, Volume: 41 Suppl 2 Topics: Adult; Aza Compounds; Bacterial Infections; Chlamydophila pneumoniae; Controlled Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2005
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:3 Topics: Adult; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Spain; Treatment Outcome	2007

Trials

16 trial(s) available for moxifloxacin and Airflow Obstruction, Chronic

Article	Year
Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD. International journal of chronic obstructive pulmonary disease, 2019, Volume: 14 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; China; Disease Progression; Drug Administration Schedule; Female; Humans; Inflammation Mediators; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Risk Factors; Sputum; Time Factors; Treatment Outcome	2019
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD. International journal of chronic obstructive pulmonary disease, 2015, Volume: 10 Topics: Age Factors; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chi-Square Distribution; Disease Progression; Double-Blind Method; Female; Fluoroquinolones; Forced Expiratory Volume; Humans; Logistic Models; Lung; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Severity of Illness Index; Sputum; Time Factors; Treatment Failure	2015
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial. Thorax, 2015, Volume: 70, Issue:10 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Load; Doxycycline; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Respiratory System; Single-Blind Method; Sputum	2015
Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease. Infection, 2016, Volume: 44, Issue:1 Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Sputum; Treatment Outcome	2016
[The efficacy and safety of moxifloxacin in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2015, Volume: 38, Issue:5 Topics: Aged; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Length of Stay; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive	2015
Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial. International journal of chronic obstructive pulmonary disease, 2015, Volume: 10 Topics: Aged; Anti-Bacterial Agents; Double-Blind Method; Drug Monitoring; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Treatment Outcome	2015
Concentration-QT analysis of the randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects. Journal of pharmacokinetics and pharmacodynamics, 2016, Volume: 43, Issue:2 Topics: Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Chlorobenzenes; Cross-Over Studies; Drug Combinations; Female; Fluoroquinolones; Healthy Volunteers; Humans; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Tablets; Topoisomerase II Inhibitors; Young Adult	2016
[No long-term effect on pathogen load]. MMW Fortschritte der Medizin, 2015, Nov-05, Volume: 157, Issue:19 Topics: Azithromycin; Bacterial Load; Doxycycline; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Sputum	2015
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. The European respiratory journal, 2009, Volume: 34, Issue:5 Topics: Aged; Anti-Infective Agents; Aza Compounds; Bacterial Typing Techniques; Bronchi; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Placebos; Polymerase Chain Reaction; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2009
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Therapeutic advances in respiratory disease, 2009, Volume: 3, Issue:6 Topics: Activities of Daily Living; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Europe; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Quinolines; Smoking; Spirometry; Surveys and Questionnaires	2009
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respiratory research, 2010, Jan-28, Volume: 11 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Placebo Effect; Pulmonary Disease, Chronic Obstructive; Quinolines; Secondary Prevention; Treatment Outcome	2010
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. International journal of chronic obstructive pulmonary disease, 2011, Volume: 6 Topics: Adrenal Cortex Hormones; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchodilator Agents; Canada; Double-Blind Method; Drug Therapy, Combination; Europe; Fluoroquinolones; Humans; Lung; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Research Design; Severity of Illness Index; Time Factors; Treatment Outcome; United States	2011
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. The European respiratory journal, 2012, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2012
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. Respiratory medicine, 2012, Volume: 106, Issue:9 Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Forced Expiratory Volume; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Recovery of Function; Risk Factors; Treatment Outcome	2012
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI). BMC pulmonary medicine, 2013, Jan-23, Volume: 13 Topics: Activities of Daily Living; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Risk Factors; Sleep Wake Disorders	2013
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respiratory medicine, 2005, Volume: 99, Issue:8 Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2005

Other Studies

15 other study(ies) available for moxifloxacin and Airflow Obstruction, Chronic

Article	Year
Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease. Scientific reports, 2023, 10-07, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Disease Progression; Humans; Moxifloxacin; Outpatients; Pulmonary Disease, Chronic Obstructive	2023
Moxifloxacin related thrombocytopeniae: A case report. Tuberkuloz ve toraks, 2016, Volume: 64, Issue:3 Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Thrombocytopenia	2016
A rare case of pleural infection due to Propionibacterium acnes (Cutibacterium acnes). Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:2 Topics: Aged; Anti-Bacterial Agents; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Pleural Diseases; Propionibacterium acnes; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections	2018
Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit Patients. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Care; Disease Progression; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive	2019
[Achilles heel of COPD]. Praxis, 2013, Jul-03, Volume: 102, Issue:14 Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Fluoroquinolones; Humans; Male; Mobility Limitation; Moxifloxacin; Ofloxacin; Prednisone; Pulmonary Disease, Chronic Obstructive; Quinolines; Respiratory Insufficiency; Rupture, Spontaneous; Ultrasonography	2013
Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease. Lung, 2013, Volume: 191, Issue:5 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Cohort Studies; Costs and Cost Analysis; Female; Fluoroquinolones; Follow-Up Studies; Forced Expiratory Volume; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Failure; Treatment Outcome	2013
A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD. American journal of physiology. Lung cellular and molecular physiology, 2016, Jan-01, Volume: 310, Issue:1 Topics: Anti-Bacterial Agents; Cell Proliferation; Fluoroquinolones; Humans; Inflammation; Interleukin-2; Lipopolysaccharides; Lymphocyte Activation; Moxifloxacin; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Th1 Cells; Toll-Like Receptor 4	2016
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary Disease. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7 Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Pulmonary Disease, Chronic Obstructive	2016
Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters. Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bronchoalveolar Lavage Fluid; Colony Count, Microbial; Cricetinae; Disease Models, Animal; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Inflammation; Lung; Male; Moxifloxacin; Neutrophils; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Quinolines; Survival Rate; Swine; Time Factors	2010
IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone. International immunopharmacology, 2011, Volume: 11, Issue:4 Topics: Aza Compounds; Case-Control Studies; CD4-Positive T-Lymphocytes; Dexamethasone; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Immunologic Factors; Interleukin-5; Male; Middle Aged; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines; Smoking; Th2 Cells	2011
Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Feb-01, Volume: 69, Issue:3 Topics: Aged; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Hyponatremia; Inappropriate ADH Syndrome; Moxifloxacin; Prednisone; Pulmonary Disease, Chronic Obstructive; Quinolines; Severity of Illness Index	2012
Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly. The European respiratory journal, 2012, Volume: 40, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2012
No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest, 2004, Volume: 125, Issue:3 Topics: Acute Disease; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2004
[Gigantic study planned. 100,000 patients with COPD test general practice antibiotic]. MMW Fortschritte der Medizin, 2004, Mar-04, Volume: 146, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Administration Schedule; Fluoroquinolones; Humans; Moxifloxacin; Multicenter Studies as Topic; Pulmonary Disease, Chronic Obstructive; Quinolines; Secondary Prevention; Treatment Outcome	2004
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. International journal of clinical practice, 2004, Volume: 58, Issue:10 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2004